Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer

Fig. 4

Survival analysis of adjuvant chemotherapy in stage II CRC patients. The upper and middle panels show RFS and OS in the training dataset respectively. The bottom panel shows RFS in the validation dataset. The entire cohort of stage II patients (the left column), Cluster 1 sub-group (the middle column) and Cluster 2 sub-group (the right column) stratified by 11-PPI-Mod predictor are analyzed respectively. The RFS/OS of patients who received adjuvant chemotherapy are compared to those of patients without adjuvant therapy. The p value is calculated by log-rank test. Abbreviations: Adj.Ther., with adjuvant chemotherapy; non-Adj.Ther., without adjuvant chemotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us